Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD

Thorax

Volumn 67, Issue 12, 2012, Pages 1075-1080

  Garcha, Davinder S ^a   Thurston, Sarah J ^a   Patel, Anant R C ^a   Mackay, Alexander J ^a   Goldring, James J P ^a   Donaldson, Gavin C ^a   McHugh, Timothy D ^a   Wedzicha, Jadwiga A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID;

AGED; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM DETECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLONY FORMING UNIT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTIPLEX POLYMERASE CHAIN REACTION; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESPIRATORY AIRFLOW; RESPIRATORY SYSTEM; SPUTUM EXAMINATION; STREPTOCOCCUS PNEUMONIAE;

EID: 84869239734     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-201924     Document Type: Article

References (34)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55. (Pubitemid 47403272)
2. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
3. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet 2007;370:786-96. (Pubitemid 47320802)
4. Rosell A, Monsó E, Soler N, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005;165:891-7. (Pubitemid 40563235)
5. Patel IS, Seemungal TA, Wilks M, et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002;57:759-64. (Pubitemid 34984972)
6. Hill AT, Campbell EJ, Hill SL, et al. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000;109:288-95.
7. Larsen JM, Steen-Jensen DB, Laursen JM, et al. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 2012;7:e31976.
8. Wilkinson TM, Patel IS, Wilks M, et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003;167:1090-5. (Pubitemid 36459654)
9. Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 2010;35:1039-47.
10. Miravitlles M, Espinosa C, Fernández-Laso E, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD*. Chest 1999;116:40-6. (Pubitemid 29340258)
11. Diederen B, van der Valk P, Kluytmans J, et al. The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;30:240-4. (Pubitemid 47194176)
12. Lieberman D, Ben-Yaakov M, Lazarovich Z, et al. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis 2001;20:698-704. (Pubitemid 33026076)
13. Lieberman D, Lieberman D, Shmarkov O, et al. Serological evidence of Legionella species infection in acute exacerbation of COPD. Eur Respir J 2002;19:392-7. (Pubitemid 34256950)
14. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
15. Hurst JR, Donaldson GC, Perera WR, et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;174:867-74. (Pubitemid 44564786)
16. Abdeldaim GM, Strålin K, Olcén P, et al. Toward a quantitative DNA-based definition of pneumococcal pneumonia: a comparison of Streptococcus pneumoniae target genes, with special reference to the Spn9802 fragment. Diagn Microbiol Infect Dis 2008;60:143-50.
17. Greiner O, Day PJ, Altwegg M, et al. Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR. J Clin Microbiol 2003;41:1386-90. (Pubitemid 36428077)
18. Nolan T, Hands RE, Ogunkolade W, et al. SPUD: a quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal Biochem 2006;351:308-10.
19. Welti M, Jaton K, Altwegg M, et al. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis 2003;45:85-95. (Pubitemid 36263020)
20. Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med 1995;152:1316-20.
21. Curran T, Coyle PV, McManus TE, et al. Evaluation of real-time PCR for the detection and quantification of bacteria in chronic obstructive pulmonary disease. FEMS Immunol Med Microbiol 2007;50:112-18. (Pubitemid 46763475)
22. Salcedo SP, Cid VJ. Nontypable Haemophilus influenzae: an intracellular phase within epithelial cells might contribute to persistence. Microbiology 2011;157:1-2.
23. Murphy TF, Brauer AL, Schiffmacher AT, et al. Persistent colonization by haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:266-72. (Pubitemid 38971411)
24. Wilkinson TM, Hurst JR, Perera WR, et al. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD*. Chest 2006;129:317-24. (Pubitemid 43289850)
25. White AJ, Gompertz S, Bayley DL, et al. Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 2003;58:680-5. (Pubitemid 36976277)
26. Daniels JM, Schoorl M, Snijders D, et al. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 2010;138:1108-15.
27. Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006;173:1114-21. (Pubitemid 43726892)
28. Huang YJ, Kim E, Cox MJ, et al. A Persistent and Diverse airway microbiota present during chronic obstructive pulmonary disease exacerbations. OMICS 2010;14:9-59.
29. Sethi S, Evans N, Grant BJ, et al. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002;347:465-71. (Pubitemid 34879333)
30. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356:775-89. (Pubitemid 46294610)
31. Wedzicha JA, Calverley PM, Seemungal TA, et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008;177:19-26.
32. Calverley PM, Stockley RA, Seemungal TA, et al. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest 2011;139:505-12.
33. Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the "Healthy" Smoker and in COPD. PLoS One 2011;6:e16384.
34. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One 2010;5:e8578.